drugset / Trial / NCT05056389

Normothermic Intraperitoneal Chemotherapy - Long Term in Peritoneal Metastases From Colorectal Cancer (NIPEC-OXA)

NCT05056389 ↗

Phase 1 Unknown 20 enrolled Oslo University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Feasibility study regarding 20 Patients with peritoneal metastases from colorectal cancer treated with cytoreductive surgery and HIPEC and subsequently with 4 courses of normothermic intraperitoneal chemotherapy - long term (NIPEC-OXA) with oxaliplatin.

Timeline

Start
2021-09-17
Primary completion
2023-03-31
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxaliplatin Small molecule — Other